Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Study of Effexor XR for the Treatment of Elderly Patients With Depression

NCT00225485 is registered in ClinicalTrials.gov with Wyeth is now a wholly owned subsidiary of Pfizer as lead sponsor.

NCT NCT00225485
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00225485 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Study of Effexor XR for the Treatment of Elderly Patients With Depression
Lead sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2003
Completion date
Not reported
Enrollment
100
Sites
37

Conditions

As the registry lists them; a condition with its own page is linked.

depression